Year-end review shows 23 new drugs approved, 14 important biologic licensing actions taken by FDA.
D015507:Drugs, Investigational; D006801:Humans; D008004:Licensure; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational